A biopharma manufacturer developing a rare disease treatment needed to quantify its potential patient population. As ICD-10 codes failed to unearth many patients or distinguish between disease sub-types, Panalgo’s data experts used unstructured EMR data to identify a much broader cohort of patients with the specific sub-type of interest. By using integrated EMR, lab and claims data, Panalgo was able to provide the manufacturer with a rich longitudinal history for all identified patients.

Download the case study to learn more.